XML 55 R57.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' equity - Stock Option Activity (Details) (USD $)
3 Months Ended 12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Exercise Price Per Share [Abstract]          
Expired, Exercise Price (usd per share) $ 0.00        
Tecogen
         
Stock Options Outstanding [Roll Forward]          
Beginning (shares) 1,148,000 1,096,500 1,096,500 1,095,250  
Granted (shares) 43,325   76,500 17,500  
Exercised (shares) (5,000)   (25,000) 0  
Canceled and forfeited (shares) 0   0 (15,938)  
Expired (shares) 0   0 (313)  
Ending (shares) 1,186,325   1,148,000 1,096,500  
Exercisable (shares) 919,250   799,500 662,563  
Vested and expected to vest (shares) 1,186,325   1,148,000    
Weighted Average Exercise Price [Roll Forward]          
Beginning (usd per share) $ 2.13 $ 1.96 $ 1.96 $ 1.92  
Granted (usd per share) $ 4.50   $ 3.86 $ 3.20  
Exercised (usd per share) $ 1.20   $ 0.12 $ 0.00  
Canceled and forfeited (usd per share) $ 0.00   $ 0.00 $ 1.28  
Expired (usd per share) $ 0.00   $ 0.00 $ 2.60  
Ending (usd per share) $ 2.22   $ 2.13 $ 1.96  
Exercisable (usd per share) $ 1.90   $ 1.79 $ 1.56  
Vested and expected to vest (usd per share) $ 2.22   $ 2.13    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]          
Outstanding, Weighted Average Remaining Life 5 years 8 months 23 days     5 years 9 months 18 days  
Outstanding, Aggregate Intrinsic Value $ 2,704,600   $ 2,721,100 $ 1,356,400 $ 1,387,150
Exercisable, Aggregate Intrinsic Value 2,387,075   2,166,550 1,096,225  
Vested and expected to vest, Aggregate Intrinsic Value 2,704,600        
Exercise Price Per Share [Abstract]          
Granted, Exercise Price (usd per share) $ 4.50     $ 3.20  
Exercised, Exercise Price (usd per share) $ 1.20   $ 0.12 $ 0  
Canceled and Forfeited, Exercise Price (usd per share) $ 0   $ 0    
Expired, Exercise Price (usd per share)     $ 0.00 $ 2.60  
Ilois
         
Stock Options Outstanding [Roll Forward]          
Beginning (shares) 575,000 575,000 575,000 525,000  
Granted (shares) 0   0 50,000  
Exercised (shares) 0   0 0  
Canceled and forfeited (shares) 0   0 0  
Expired (shares) 0   0 0  
Ending (shares) 575,000   575,000 575,000 525,000
Exercisable (shares) 125,000   0 0  
Vested and expected to vest (shares) 575,000   575,000    
Weighted Average Exercise Price [Roll Forward]          
Beginning (usd per share) $ 0.29 $ 0.29 $ 0.29 $ 0.27  
Granted (usd per share) $ 0.00   $ 0.00 $ 0.50  
Exercised (usd per share) $ 0   $ 0.00 $ 0.00  
Canceled and forfeited (usd per share) $ 0   $ 0.00 $ 0.00  
Expired (usd per share) $ 0   $ 0.00 $ 0.00  
Ending (usd per share) $ 0.29   $ 0.29 $ 0.29 $ 0.27
Exercisable (usd per share) $ 0.50   $ 0.50 $ 0.00  
Vested and expected to vest (usd per share) $ 0.29   $ 0.29 $ 0.29  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]          
Outstanding, Weighted Average Remaining Life 6 years 2 months 9 days 6 years 5 months 9 days 6 years 5 months 9 days 7 years 5 months 7 days 8 years 2 months 22 days
Outstanding, Aggregate Intrinsic Value 120,000   120,000 120,000 120,000
Exercisable, Aggregate Intrinsic Value 0   0 0  
Vested and expected to vest, Aggregate Intrinsic Value $ 120,000   $ 120,000 $ 120,000  
Exercise Price Per Share [Abstract]          
Granted, Exercise Price (usd per share) $ 0.00   $ 0.00 $ 0.50  
Exercised, Exercise Price (usd per share) $ 0   $ 0 $ 0  
Canceled and Forfeited, Exercise Price (usd per share) $ 0   $ 0 $ 0  
Expired, Exercise Price (usd per share) $ 0   $ 0 $ 0  
Stock options | Tecogen
         
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Expected life     5 years 7 months 18 days 6 years 3 months  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]          
Outstanding, Weighted Average Remaining Life     5 years 9 months 20 days 4 years 7 months 28 days 5 years 6 months 11 days
Exercise Price Per Share [Abstract]          
Risk-free interest rate     1.34% 0.70%  
Stock options | Ilois
         
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Expected life       6 years 3 months  
Exercise Price Per Share [Abstract]          
Risk-free interest rate       2.03%  
Restricted stock | Tecogen
         
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 361,570   361,570 399,070 483,317
Exercise Price Per Share [Abstract]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 1.31   $ 1.31 $ 1.44 $ 1.44
Granted (shares) 0   0 0  
Granted (usd per share) $ 0.00   $ 0.00 $ 0.00  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 0   0 0  
Vested (usd per share) $ 0   $ 0.00 $ 0.00  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 0   37,500 84,247  
Forfeited (usd per share) $ 0.00   $ 2.60 $ 1.36  
Restricted stock | Ilois
         
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number     310,000 510,000  
Exercise Price Per Share [Abstract]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 0.10   $ 0.10    
Granted (shares) 0        
Granted (usd per share) $ 0.00        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 0        
Vested (usd per share) $ 0.00        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 0        
Forfeited (usd per share) $ 0.00